Qiagen NV (QGEN) financial statements
Qiagen NV reported revenue of $2.1B in fiscal 2025, up 5.1% a year over 9 years.
Net income was $425M and the operating margin 22.3%, against 7.4% in 2016.
Free cash flow was $453M, and the company returned $54M in dividends and $280M in net buybacks.
The diluted share count fell 8% over the period (buybacks).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Qiagen NV's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.5B | $1.5B | $1.9B | $2.3B | $2.1B | $2.0B | $2.0B | $2.1B |
| Cost of revenue | $493M | $495M | $501M | $521M | $638M | $801M | $757M | $732M | $1.0B | $791M |
| Gross profit | $845M | $923M | $1.0B | $1.0B | $1.2B | $1.5B | $1.4B | $1.2B | $967M | $1.3B |
| Research and development | $150M | $154M | $162M | $157M | $149M | $190M | $190M | $199M | $193M | $188M |
| Selling, general and admin | — | $478M | $497M | $504M | $525M | $584M | $604M | $579M | $564M | $584M |
| Operating income | $99M | $153M | $267M | -$26M | $386M | $630M | $531M | $410M | $98M | $466M |
| Interest expense | $39M | $50M | $67M | $74M | $71M | $54M | $58M | $53M | $44M | $33M |
| Pre-tax income | $57M | $114M | $226M | -$78M | $439M | $626M | $513M | $430M | $121M | $490M |
| Income tax | -$23M | $74M | $35M | -$36M | $80M | $113M | $89M | $89M | $38M | $65M |
| Net income | $80M | $40M | $190M | -$41M | $359M | $513M | $423M | $341M | $84M | $425M |
| EPS (diluted) | $0.34 | $0.17 | $0.82 | -$0.18 | $1.53 | $2.21 | $1.84 | $1.48 | $0.37 | $1.94 |
| Diluted shares | 239M | 233M | 233M | 227M | 234M | 232M | 230M | 231M | 225M | 219M |
| Gross margin | 63.1% | 65.1% | 66.6% | 65.9% | 65.9% | 64.4% | 64.7% | 62.8% | 48.9% | 62.2% |
| Operating margin | 7.4% | 10.8% | 17.8% | -1.7% | 20.7% | 28.0% | 24.8% | 20.9% | 4.9% | 22.3% |
| Net margin | 6.0% | 2.8% | 12.7% | -2.7% | 19.2% | 22.8% | 19.8% | 17.4% | 4.2% | 20.3% |
Balance sheet
Fiscal years, from Qiagen NV's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $532M | $1.0B | $1.4B | $753M | $715M | $1.1B | $1.4B | $1.1B | $1.2B | $1.1B |
| Receivables | $278M | $329M | $352M | $385M | $381M | $362M | $324M | $382M | $349M | $403M |
| Inventory | $137M | $156M | $163M | $171M | $291M | $328M | $358M | $398M | $279M | $302M |
| Total current assets | $1.0B | $1.6B | $2.2B | $1.6B | $1.6B | $2.1B | $2.4B | $2.1B | $2.0B | $2.0B |
| Property, plant and equipment | $437M | $494M | $512M | $455M | $559M | $638M | $662M | $765M | $754M | $924M |
| Goodwill | $1.9B | $2.0B | $2.1B | $2.1B | $2.4B | $2.4B | $2.4B | $2.5B | $2.4B | $2.7B |
| Total assets | $4.3B | $5.0B | $5.7B | $5.2B | $5.9B | $6.1B | $6.3B | $6.1B | $5.7B | $6.3B |
| Total current liabilities | $308M | $325M | $972M | $951M | $572M | $1.5B | $975M | $1.1B | $1.0B | $512M |
| Long-term debt | $1.1B | $1.8B | $1.7B | $1.4B | $1.9B | $1.1B | $1.5B | $922M | $840M | $1.7B |
| Total liabilities | $1.7B | $2.5B | $3.1B | $2.7B | $3.1B | $3.1B | $2.8B | $2.3B | $2.1B | $2.5B |
| Shareholders' equity | $2.6B | $2.5B | $2.6B | $2.5B | $2.8B | $3.1B | $3.5B | $3.8B | $3.6B | $3.8B |
| Net debt | $628M | $1.1B | $1.0B | $1.1B | $1.3B | $1.1B | $1.1B | $842M | $728M | $815M |
Cash flow
Fiscal years, from Qiagen NV's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $342M | $287M | $359M | $331M | $458M | $639M | $715M | $459M | $674M | $654M |
| Capital spending | $75M | $90M | $110M | $118M | $133M | $190M | $129M | $150M | $167M | $201M |
| Free cash flow | $267M | $197M | $250M | $213M | $325M | $449M | $586M | $310M | $506M | $453M |
| Stock-based compensation | $28M | $34M | $40M | $66M | $41M | $38M | $50M | $47M | $44M | $50M |
| Dividends paid | — | — | — | — | — | — | — | $0 | $0 | $54M |
| Share buybacks (net) | $0 | -$61M | -$105M | -$74M | -$64M | -$100M | $0 | $0 | -$292M | -$280M |
| Net borrowing | -$7M | $330M | $0 | -$506M | $201M | -$41M | -$109M | -$400M | -$107M | $208M |
| Free cash flow margin | 20.0% | 13.9% | 16.6% | 13.9% | 17.4% | 19.9% | 27.4% | 15.8% | 25.6% | 21.7% |
| Dividends per share | — | — | — | — | — | — | — | — | — | $0.25 |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for QGEN.
Open QGEN in InvestinglyQuestions
What was Qiagen NV's revenue in 2025?
$2.1B in fiscal 2025, from its 10-K filing.
How much free cash flow does Qiagen NV generate?
$453M in fiscal 2025 (operating cash flow minus capital spending).
From Qiagen NV's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.